Filter Results:
(75)
Show Results For
- All HBS Web
(323)
- News (75)
- Research (185)
- Events (1)
- Multimedia (3)
- Faculty Publications (46)
Show Results For
- All HBS Web
(323)
- News (75)
- Research (185)
- Events (1)
- Multimedia (3)
- Faculty Publications (46)
Page 1 of 75
Results →
Sort by
- 29 Oct 2015
- News
Options to Promote Competitive Generics Markets in the United States
- 01 Mar 2004
- News
Drug Imports a Hot Topic at Alumni Health-Care Conference
FDA Commissioner Mark B. McClellan doesn’t approve of Americans buying low-cost prescription drugs from Canada or over the Internet. But he understands what drives them to do so. At the HBS Health Industry Alumni Association’s fourth... View Details
- 01 Mar 2007
- News
Daniel Vasella
sales of $37 billion. The company’s aggressive investment in research has made it an industry leader in new drug approvals. And when opportunity knocks, Vasella doesn’t hesitate to broaden Novartis’s business mix through acquisitions. He... View Details
- 13 Oct 2016
- News
Study shows coupons lead to big profits for drugmakers
- 01 Dec 2023
- News
Wide Horizon
two bigger players begin to invest in the drug for ASD. He wasn’t frustrated by the competition; he was relieved. Getting new ideas to market is a positive outcome, no matter who takes it there. “I want to focus on View Details
Keywords: Dan Morrell; Photos by Sarah Wilson
- 01 Sep 2023
- News
Solving for Z
With nearly 20 years of experience as a senior human resources executive, Matthew Breitfelder (MBA 2002) has seen a lot of change in the corporate talent space. But what’s happening now looks like a tectonic generational shift. From his perch as global head of human... View Details
- 04 Apr 2024
- News
The Making of a Medical Milestone
On March 16, doctors at the Massachusetts General Hospital made history when they successfully transplanted a kidney from a genetically modified pig to a living human. The groundbreaking procedure marked a significant milestone in animal-to-human transplant, or... View Details
Keywords: Margie Kelley
- 01 Jun 2024
- News
Quantum Leap
“This is the first new kind of computer in 75 years,” says John Levy (MBA 1979), CEO of the quantum computing startup SEEQC. “And we’re building it on a chip!” Strolling through his company’s design and testing facility in Elmsford, New York, Levy looks less like a... View Details
- 01 Mar 2024
- News
Alumni and Faculty Books and Podcasts
this compelling, generous, and inspiring memoir, Marsha reckons with the way trauma spreads from generation to generation and person to person, and learns that the effects of trauma need not last a lifetime.... View Details
- 01 Oct 2021
- News
From Scholarship to Life-Saving Impact
Nora Rabah (MS/MBA 2022), who emigrated to the United States as a child, remembers the hardship of growing up without health care and wants to make drugs for children with rare diseases more accessible and affordable. Nora Rabah’s (MS/MBA... View Details
- 01 Jun 2023
- News
From Big Pharma to Startup
School clubs he had joined, he decided to apply. “It was just curiosity,” Goble says. The program, now known as Nucleate, which is dedicated to empowering the next generation of biotech leaders, hosted what Goble remembers as a kind of... View Details
Keywords: April White
- 01 Dec 2017
- News
2017 in Health Care: Telemedicine Has Arrived
drug and the FDA says it is safe and effective and doctors prescribe it, insurance generally will pay for it. But everyone is getting fed up with that approach—the ‘Pharma bro’ Martin Shkreli did not... View Details
- 01 Sep 2004
- News
American Dream
passing motorists. Hustead acquired the T. rex, for example, to drive demand for the fossils, rocks, and dinosaur-related products for sale in the Wall Drug Mining Company, one of 21 separate retail departments that View Details
- 01 Dec 2019
- News
The Race Against Resistance
tide. “If we don’t take steps to slow down or stop drug resistance, we will fall back to a time when simple infections killed people. Can you imagine? That’s a bit of a doomsday perspective, but it’s a call to action.” “We are approaching... View Details
Keywords: Lisa Scanlon Mogolov
- 01 Jun 2001
- News
Stephen M. Moret: A Campaign for Positive Change
low-cost HIV/AIDS drugs to Malawi. “I’m the guy who still can’t believe I got to go to school here.” After traveling around the world this fall, Moret will take a position in McKinsey’s Washington, D.C., office, where he hopes to spend... View Details
- 01 Jan 2002
- News
Raymond V. Gilmartin (MBA '68)
wants to understand the barriers to effecting change on global issues such as health care." Under Ray Gilmartin's leadership, Merck has launched an unprecedented number of new drugs and forged partnerships with the public and nonprofit... View Details
- 15 Dec 2024
- News
After Ozempic
Back before Ozempic, when Kate Mulroney (MBA 1984) spoke at technical conferences about her work at Novo Nordisk, people often assumed she was talking about Novartis. “I’d have to explain that’s a Swiss company; we’re Danish,” says Mulroney, now head of advanced... View Details
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
consulting firm Shaldor, documents the specific strategies various companies pursued. As examples, by focusing on a neglected market segment, Netafim became the world leader in drip irrigation technology, while Teva Pharmaceutical created a scalable, acquisition-based... View Details
- 20 Aug 2014
- News
With No Time to Lose
into ALS research, and removed some critical barriers to the development of treatments. “Our focus, from the start, was to get drug companies to invest money in ALS,” says Kremer, who was diagnosed with the disease in 2004, just weeks... View Details
Keywords: Margie Kelley